Transplantation of encapsulated cells releasing NGF to the basal forebrain in a small number of AD patients showed good safety/tolerability and supportive biomarker data, where immunohistochemical analysis and cognitive tests suggested signs of improved neuronal function and cognition in response to the secreted NGF [24,25,26]. Here, NGF is linked to Alzheimer disease.